Correlation Between VistaGen Therapeutics and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and AstraZeneca PLC ADR, you can compare the effects of market volatilities on VistaGen Therapeutics and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and AstraZeneca PLC.
Diversification Opportunities for VistaGen Therapeutics and AstraZeneca PLC
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between VistaGen and AstraZeneca is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and AstraZeneca PLC
Given the investment horizon of 90 days VistaGen Therapeutics is expected to under-perform the AstraZeneca PLC. But the stock apears to be less risky and, when comparing its historical volatility, VistaGen Therapeutics is 1.0 times less risky than AstraZeneca PLC. The stock trades about -0.32 of its potential returns per unit of risk. The AstraZeneca PLC ADR is currently generating about -0.27 of returns per unit of risk over similar time horizon. If you would invest 7,505 in AstraZeneca PLC ADR on August 26, 2024 and sell it today you would lose (942.00) from holding AstraZeneca PLC ADR or give up 12.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. AstraZeneca PLC ADR
Performance |
| Timeline |
| VistaGen Therapeutics |
| AstraZeneca PLC ADR |
VistaGen Therapeutics and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and AstraZeneca PLC
The main advantage of trading using opposite VistaGen Therapeutics and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Histogen | VistaGen Therapeutics vs. Entera Bio |
| AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |